Prestige Consumer Healthcare
PBH
C$102.78
Share price
-2.16%
Change (1 day)
5.37%
Change (1 year)
Categories
Earnings for Prestige Consumer Healthcare (PBH)
Earnings in 2025 (TTM): C$0.39 Billion
According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are C$1.13 Billion. In 2024 the company made an earning of C$0.38 Billion, an increase over its 2023 earnings that were of -C$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Prestige Consumer Healthcare from 2005 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | C$0.39 B | 4.21% |
| 2024 | C$0.38 B | -405.61% |
| 2023 | -C$0.13 Billion | -134.07% |
| 2022 | C$0.36 B | 10.21% |
| 2021 | C$0.33 B | 12.88% |
| 2020 | C$0.29 B | -657.8% |
| 2019 | -C$52.9 Million | -143.45% |
| 2018 | C$0.12 B | -50.46% |
| 2017 | C$0.24 B | 52.98% |
| 2016 | C$0.16 B | -31.39% |
| 2015 | C$0.23 B | 45.68% |
| 2014 | C$0.16 B | 10.59% |
| 2013 | C$0.14 B | 38.24% |
| 2012 | C$0.10 B | 8.79% |
| 2011 | C$96.61 M | 55.18% |
| 2010 | C$62.26 M | -123.77% |
| 2009 | -C$0.27 Billion | -446.47% |
| 2008 | C$75.6 M | 8.03% |
| 2007 | C$69.98 M | -3.71% |
| 2006 | C$72.68 M | 42.33% |
| 2005 | C$51.06 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 GlaxoSmithKline GSK | C$7.44 B | 1,802.54% | 🇬🇧 UK |
 Pfizer PFE | C$14.23 B | 3,538.78% | 🇺🇸 USA |
 Rite Aid
RAD | -C$1.92 Billion | -589.70% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$37.73 B | 9,544.29% | 🇺🇸 USA |
 Taro Pharmaceutical TARO | C$60.2 M | -84.61% | 🇮🇱 Israel |
 Novartis NVS | C$20.54 B | 5,149.32% | 🇨🇭 Switzerland |
 Procter & Gamble PG | C$28.13 B | 7,089.23% | 🇺🇸 USA |
 CVS Health CVS | C$14.06 B | 3,493.38% | 🇺🇸 USA |
 Clorox CLX | C$1.29 B | 231.82% | 🇺🇸 USA |
 Abbott Laboratories ABT | C$10.12 B | 2,488.07% | 🇺🇸 USA |